Advancing Postmenopausal Preventive Therapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 385 participants.
Also called NCT04103476
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 385 participants
- Registry
-
NCT04103476
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04103476. Randomized; quadruple masking; primary purpose treatment. Start 2021-04-13 (actual); primary completion 2026-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Advancing Postmenopausal Preventive Therapy
- Acronym
- APPT
- Condition
- Atherosclerosis
- Condition
- Cognitive Decline
- Intervention (Combination product)
- Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg
- Intervention (Other)
- Placebo
- Lead sponsor
- University of Southern California
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct04103476- Content hash
284345e10bceb8bda03c806559f5386a423e4eac7ca014b086bb24728d13d08e